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ABSTRACT A rat brain cDNA library has been con-
structed in a Saccharomyces cerevisiae expression vector and
used to isolate genes that can function in yeast to suppress the
phenotypic effects ofRAS2vaII9, a mutant form oftheRAS2 gene
analogous to an oncogenic mutant of the human HRAS gene.
One cDNA, DPD, was cloned and its genetic and biochemical
properties were characterized. A DPD product would share
80% amino acid sequence identity with the Drosophila mela-
nogaster dunce-encoded protein over an extended region. We
have shown that the DPD protein is a high-affinity cAMP-
specific phosphodiesterase.
The yeast Saccharomyces cerevisiae encodes two genes,
RAS] and RAS2, that have structural and functional homol-
ogy with mammalian RAS oncogenes (1-4). When an acti-
vated form of the RAS2 gene (RAS2vall9) is present, yeast
cells fail to synthesize glycogen, are unable to arrest in G1, are
intolerant of nutrient starvation, and are acutely sensitive to
heat shock (5, 6). These phenotypes, collectively referred to
as loss of growth control, are primarily the result of overex-
pression or uncontrolled activation of the cAMP effector
pathway via adenylyl cyclase (2, 5, 7, 8).
We have previously reported the isolation of two yeast
genes, PDEJ and PDE2, the low- and high-affinity cAMP
phosphodiesterase-encoding genes, respectively, by their
ability to suppress the heat shock sensitivity in yeast cells
harboring an activated RAS2Va"l9 gene (6, 9). We now report
the use of a rat brain cDNA library to clone a mammalian
cDNA that is able to complement the loss of growth control
associated with this activated RAS2 gene in yeast.t The gene,
DPD (dunce-like phosphodiesterase), encodes a high-affinity
cAMP phosphodiesterase that is highly homologous to the
cAMP phosphodiesterase encoded by the dunce locus of
Drosophila melanogaster. D. melanogaster with mutations
in dunce have learning and memory defects (10, 11).
MATERIALS AND METHODS
Strains, Media, Transformations, and Heat Shock. Esche-
richia coli strain HB101 was used for plasmid propagation
and isolation, and strain SCS1 (Stratagene) was used for
transformation and maintenance of the cDNA library (12, 13).
S. cerevisiae strains TK161-R2V (MATa leu2 his3 ura3 trpl
ade8 can] RAS2Vail9) (5) and 10DAB (MATa leu2 his3 ura3
ade8 pdel::ADE8 pde2::URA3 rasl::HIS3) were used.
10DAB was created from a segregant of a diploid strain
produced by mating TS-1 (14) and DJ23-3C (15). The segre-
gant (MATa leu2 his3 ura3 ade8 pdel::LEU2 pde2::URA3
rasl::HIS3) was subsequently transformed with the 5.4-
kilobase-pair (kbp) Xba I pdel ::ADE8 fragment of pYT19-
DAB to yield strain 10DAB. Yeast cells were grown in either
rich medium (YPD, yeast extract/peptone/dextrose) or syn-
thetic medium with appropriate auxotrophic supplements
(SC) (16). Transformation of yeast cells was performed with
lithium acetate (17). Heat shock experiments were performed
by replica plating onto preheated SC plates that were main-
tained at 550C for 10 min, allowed to cool, and incubated at
30'C for 24-48 hr. Segregation analysis was performed by
growing yeast transformants in YPD for 2-3 days, plating
onto YPD plates, and replica plating onto YPD, SC-leucine
(plasmid selection), and YPD heat shock plates.
Plasmids, DNA Manipulations, and Sequencing. Plasmid
DNA from individual E. coli colonies was purified by stan-
dard procedures (18, 19). Extrachromosomal DNA was iso-
lated from yeast as described (9). The plasmid pYT19DAB
was constructed from pYT19 (9) by first deleting PDEJ
sequences between the Sma I and Bal I restriction sites to
yield pYT19D. The 4-kbp BamHI fragment of the ADE8 gene
was then inserted into the BamHI site of pYT19D to yield
pYT19DAB. The cloning vector pADNS is based on the
plasmid pAD1 previously described (20). pADNS consists of
a 2.2-kbp Bgl II/Hpa I fragment containing the S. cerevisiae
LEU2 gene from YEp213 (21), a 1.6-kbp Hpa I/HindIlI
fragment of the S. cerevisiae 2-,um plasmid containing the
origin of replication, and a 2.1-kbp Ssp I/EcqRI fragment
containing the ampicillin-resistance gene from' the plasmid
pUC18. It also contains a 1.5-kbp BamHI/HindIII fragment
of the modified S. cerevisiae alcohol dehydrogenase (ADHI)
promoter (22, 23) and a 0.6-kbp HindIII/BamHI fragment
containing the ADHI terminator sequences. The promoter
and terminator sequences are separated by a polylinker that
contains the restriction endonuclease sites Not I, Sac II, and
Sfi I between the existing HindIII and Sac I sites. The
oligonucleotides used to create these sites were 5'-GG-
CCAAAAAGGCCGCGGCCGCA and 5'-TCGACCGGTTT-
TTCCGGCGCCGGCGTTCGA. The plasmid pADPD is a
pADNS-derived plasmid containing the 2.17-kb DPD cDNA
insert.
Sequencing was performed by the dideoxynucleotide
chain-termination method (24, 25). GENALIGN was used to
align the DPD and dunce sequences (GENALIGN is a copy-
righted software product of IntelliGenetics; developed by
Hugo Martinez). RNA was purified from Sprague-Dawley
rat brains by published procedures (26-28). cDNAs were
ligated to the Not I linker oligonucleotides 5'-AAGCG-
GCCGC and 5'-GCGGCCGCTT. The cDNAs were cleaved
with Not I and cloned into the Not I site of pADNS by
standard procedures.
Polymerase chain reactions (PCRs) were carried out in a
thermocycler (Perkin-Elmer/Cetus) using a modification of
Abbreviation: PCR, polymerase chain reaction.
*To whom reprint requests should be addressed.
tThe sequence reported in this paper is being deposited in the
EMBL/GenBank data base (accession no. J04563).
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published procedures (29). Reaction mixtures contained tem-
plate DNA (1 ng of cloned DNA or 1 Ag of total first strand
cDNA), 25 pmol of oligonucleotide primers, 200 ,uM deoxy-
ribonucleotide triphosphates, 10 mM Tris HCl (pH 8.4), 50
mM KCI, 3 mM MgCI2, and 0.01% (wt/vol) gelatin. The
oligonucleotide primers used, as designated in Fig. 3, were as
follows: A, 5'-CACCCTGCTGACAAACCT"; B, 5'-ATGG-
AGACGCTGGAGGAA53; C, 5'-ATACGCCACATCAGA-
ATG676; D, 5'-TACCAGAGTATGATTCCC'449; E, 5'-GTG-
TCGATCAGAGACTTG'66; F, 5'-GCACACAGGTTGGC-
AGAC24. The numbers indicate position coordinates in Fig.
2. Primers C, E, and F are noncoding strand sequences.
Thirty cycles (1.5 min at 940C, 3 min at 550C, and 7 min at
720C) were performed and the reaction products were ana-
lyzed by polyacrylamide gel electrophoresis.
Phosphodiesterase Assays. Yeast cells were grown at 30'C
for 36 hr in 1-liter cultures of synthetic medium (SC-leucine).
Cells were harvested and washed with buffer C (20 mM
Mes/0.1 mM MgCI2/0.1 mM EGTA/1 mM 2-mercapto-
ethanol), were resuspended in 30 ml of buffer C with 50 I-l of
1 M phenylmethylsulfonyl fluoride, and were disrupted with
a French press. The extracts were centrifuged at 1600 x g for
10 min and the supernatants were spun at 18,000 x g for 90
min (4°C). The supernatant was assayed for phosphodi-
esterase activity (6, 9). All the reaction mixtures contained
Tris HCI (pH 7.5) (100 mM), cell extract (50 ,g of protein per
ml), 5'-nucleotidase (20 ng/ml; Sigma), and Mg2+ (10 mM)
(unless otherwise stated) and the indicated cyclic nucleotide
concentrations. Assays for cGMP hydrolysis used 1.5 ,M
cGMP. Inhibition studies used 5 ,uM cAMP in the presence
of various amounts of cGMP up to 500 ,AM. [3H]cAMP and
[3H]cGMP were from NEN. Reaction mixtures were incu-
bated for 10 min at 30°C and stopped with 5x stop solution
(250 mM EDTA/25 mM AMP/100 mM cAMP).
RESULTS
A Mammalian Gene That Can Revert the Heat Shock
Sensitivity of RAS2val9 Yeast. We have previously described
the isolation of several yeast genes that when overexpressed
on extrachromosomal yeast vectors are capable of suppress-
ing the heat shock sensitivity exhibited by the RAS2val9_
expressing strain TK161-R2V (6, 9). We have now used the
same selection to isolate mammalian genes that can function
in yeast to render RAS2Va`l9 cells resistant to heat shock. A
rat brain cDNA library was produced and cloned into the
yeast expression vectorpADNS (Fig. 1). cDNAs were ligated
to Not I linkers, cleaved with Not I restriction enzyme, and
cloned into pADNS at the Not I site situated between the
alcohol dehydrogenase promoter and termination sequences.
The use of the rare cutting Not I obviated the need for
restriction site methylases commonly used in cDNA cloning.
Approximately 1.5 x 105 independent cDNA inserts were
contained in the library, with an average insert size of 1.5
kbp. DNA prepared from the cDNA expression library was
used to transform the RAS2Vall9 yeast strain TK161-R2V. The
50,000 Leu+ transformants obtained were subsequently
tested for heat shock sensitivity. Only one transformant
displayed heat shock resistance which was conditional upon
retention of the expression plasmid. A plasmid, pADPD, was
isolated from this transformant and the 2.17-kb Not I insert
was analyzed by restriction site mapping (Fig. 1) and nucle-
otide sequencing (24, 25) (Fig. 2).
A large open reading frame of 562 codons was found. The
first ATG, however, appears at codon 46 and a protein that
initiates at this codon would have a predicted molecular mass
of -60 kDa. A second shorter open reading frame, separated
from the first by three stop codons but in the same frame as
the principal coding region, contains 116 codons. The nucle-
otide sequence of the coding strand ends with a stretch of
A
Xba
HindM/NotI/SocIl/Sfi/ Eco RI
B
N NsD P Sa K S PS P X NI_
lOObp
FIG. 1. Restriction maps ofexpression vector and isolated insert.
(A) The expression vector pADNS is described in detail in Materials
and Methods. It contains selectable markers for use in yeast (LEU2),
and bacteria (AMPR), as well as yeast and bacterial origins of
replication. The yeast alcohol dehydrogenase sequences are shown
with the Not I cloning site located between them. (B) The DPD
cDNA insert is shown as a 2.17-kbp Not I fragment. N, Not I; Ns,
Nsi I; D, Dra I; P, Pvu II; Sa, Sac I; K, Kpn I; S, Stu I; X, Xba I.
The cDNA is presented with the coding strand oriented 5' (left) to 3'
(right).
poly(A). A search for similar sequences was performed and
the D. melanogaster dunce gene was found. The two genes
would encode proteins with an 80% amino acid identity,
without the introduction of gaps, over a 252-amino acid
region located in the center of the rat DPD cDNA. The dunce
gene has been shown to encode a high-affinity cAMP phos-
phodiesterase (30-32).
To demonstrate that the sequences upstream and down-
stream of the large sequence identity region were in fact
contiguous with that region in the mRNA rather than artifacts
of our method for cDNA cloning, we compared the structure
of our cloned cDNA with DPD cDNAs contained in an
independently prepared first strand cDNA population ob-
tained by reverse transcribing total rat brain poly(A)+ RNA
with an oligo(dT) primer. Oligonucleotide primers comple-
mentary to sequences located within the identity region, and
to sequences near the 5' or 3' ends of the coding strand, were
made. Using either the cloned DNA or the total first-strand
cDNA material as template, PCRs were carried out using four
different primer sets and the reaction products were analyzed
by polyacrylamide gel electrophoresis (Fig. 3). In each case,
a fragment of the predicted length was obtained by using
either of the template DNAs. The band assignments were
confirmed by cleavage with restriction endonucleases having
recognition sites within the amplified DNA product. Again,
in each case, the primary PCR product obtained using either
source oftemplate yielded cleavage products of the predicted
sizes. Some submolar background bands do appear in the
PCR products but these were unaffected by the restriction
digests. The results indicate that the sequence arrangement in
the cloned cDNA faithfully reflects the structure of the rat
mRNA.
Expression and Characterization of the DPD Gene Product.
S. cerevisiae encodes two cAMP phosphodiesterase genes,
PDEJ and PDE2 (6, 9). The strain 10DAB carries disruptions
of both of these genes. The resulting cAMP phosphodi-
esterase deficiency leads to elevated intracellular cAMP
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1 AGC TTG CGA ATC GTA AGA AAC AAT TTC ACC CTG CTG MCA AAC CT? CAC GGA GCA CCG AAC MG AGG TCG CCA GCG GC7 AGT CAG GCT CCA GTC ACC MGA GTC AMC CTG1 Ssr Len Arg lie Val Mrg Msn Asn Phs Thr Len Len Thr Asn Lsu His Giy Aia Pro AMn Lys Arg Ser Pro Ala Al& Ser Gin Ala Pro Val Thr Arg Val Ser Len
III III III III III
1 Het Ph. Gin His Gin Thr Aen Pro Giy Giy Pro Thr Msn Arg Arg Mg Pro Arg Asp Gin Giu Ile His Gin Giu Pro Mrg Tyr Pro Lys
109 CAAL GAA GAA IdA TAT CMG AMA CIA GCA ATG GMAG dICG GMG GM CTA GMC TGG TGC CIA GMC CMG CIA GMG AC ATC CMG MC TMC CGC IC? GTC MGC GMG ATG GCT37 Gin Gin Giu Ser Tyr Gin Lys Len Ala Net Gin Thr Len Giu Giu Lon Asp Trp Cys Len Asp Gin Lsu Giu Thr Ile Gin Thr Tyr Mrg Ser Vai SMr Gin Net Ala
31 Ala Mrg Gly His Thr Pro Ala Trp Pro Pro Thr Gin Ocr Mrg Ssr Trp Thr Giy Ala SMr Thr SMr Trp Mrg Pro Ssr Mrg Pro Ii. Ala Ala SMr Pro Thr Trp Mrg
2i7 ?CA AMC AMG TIC AMA MG ATG CTG MAC CGG GMG CTG McA Cm CIC TCA GAG AIG MC MGA ICA GGG AMC GM GTG IC? GMA TM AT? ICG AMC MG TIC TIA GMC AMG73 SMr AMn Lys Ph. Lys Mrg Met Len Msn Mrg Gin Len Thr His Len, Mr Gin Met Mer Mrg Mr Giy Msn Gin Vai Ssr Gin Tyr Ile Sar Mn Thr Ph. Len Asp Lys
III III III III III III III III III III III III III III III III III III III III III III III III III
67 Mrg Len Mor Cys Lys Mrg Net Len Msn Lys Gin Len Ssr His Ph. Mer Gin Mer Ssr Mrg Mer Giy Msn Gin Ile Sor Gin Tyr Ii. Cys Ser Thr Pbs Len Asp Lys
325 CMG AMC GAT GIG GM AIC CCA ICT CCC MCC CMG AG GMC AM GMG AMG AMG AMG AM CM CMi09 Gin Msn Asp Val Gin Ils Pro Ssr Pro Thr Gin Lys Asp Mrg Gin Lys Lye Lye Lys Gin Gin
III III III III III III
103 Gin Gin Gin Ph. Asp Len Pro Ser Len Mrg Vai Gin Asp Msn Pro Gin Len Vai Ala Ala Msn Ala Ala Ala Giy Gin Gin Mor Ala Giy Gin Tyr Ala Mrg Mr Mrg
388 CIC ATG ACC CMG ATA MGT GGA GIG AMG AMA CIG ATG CMC MC TCA AMC CIG AC AAM MA MCC AIC TCA CGC TI? OGA GIC AMC MG GMA130 Len Met Thr Gin lie Ser Giy Vai Lye Lye Len Met His Ser Mer Mor Len Msn Msn Thr Ser Ilie Ser Mrg Ph. Giy Vai Msn Thr Gin
III III III III III III III III III III III III III III
145 M~r Pro Mrg Giy Pro Pro Met Ser Gin Ilie Ser Giy Vai Lye Mrg Pro Len Ser His Thr Msn Mer Ph. Thr Gly Gin Mrg Len Pro Thr Ph. Giy Vai Gin. Thr Pro
478 MIT GMG GAT CAT CIA GCC AMG GMG CTG GMA GAC CIG AAM AMA TOG GGC CIT MAC AIC TIC AMC GIG GCT GGG TMC ICC CAT MAT CGG CCC CIC MCA TOC AIC AIG TMC160 Msn Gin Asp His Len Ala Lye Gin Len Gin Asp Len Msn Lye Trp Giy Len Msn lIe Pbs Msn Val Ala Giy Tyr Mor His Msn Mrg Pro Len Thr Cys Ii. Met Tyr
III III III III III III III III III III III III III III III III181 Mgq Gin Men Gin Len Giy Thr Len Len Gly Gin Len Msp Thr Trp Gly Ile Gin Ile Ph. Mer Ile Gly Gin Ph. Mer Val Msn Mrg Pro Len Thr Cys Vai Ala Tyr
586 GCC AT? TIC CM GMA MAG GA CII CIA AMG MG TTT AMA AIC ICC ICC GAC MC TIC GTA MCC TMC AG ATG MT? TTA GMA GM CAT TMC CAT ICT CAT GIG GCG TAT
196 Ala le Phe Gin Gin Mrg Asp Len Len Lys Thr Ph. Lye Ile Ser Mer Msp Thr Ph. Val Thr Tyr Met Met Thr Lenu Gin. Asp His Tyr His Ser Asp Val Ala Tyr
III III III III III III III III III III III III III III III III III
217 Thr Ile Phe Gin Ser Mrg Gin Len Len Thr Ser Len Met Ile Pro Pro Lye Thr Ph. Len Msn Phs Met Mer Thr Len Gin, Asp His Tyr Val Lye Asp Msn Pro Phe
694 CMC AAM MC CTG CMC OCT OCT GMC GIG GCC CMG TCA ACG CMC GTl CIC CIC ICI MCG CCA GCA dIG CAT GCT GIC TIC MCA GMC CTG GM& AIC CIG GCT GCC All TTT
232 His Msn Ser Len His Ala Ala Asp Vai Ala Gin Ser Thr His Val Len Len Ser Thr Pro Ala Len Asp Ala Vai Phe Thr Asp Len Gin Ile Len Ala Ala Ile Phe
IIIIII I I III III II III III 1IIII 1I I1 II I1III1IIIItI1111 1III II III III253 His Msn Ser Len His Ala Ala Asp Vai Thr Gin Ser Thr Msn Vai Len Len Msn Thr Pro Ala Len Gin Giy Val Ph. Thr Pro Len Gin Val Giy Giy Ala Len Phe
802 GCA GCT GCC AIC CAT GAT GTl GAl CAT CCI GGA GTC ICC MAT CMG IT? CTC AIC MT? MA AMT TCC GMA CT? OCT TTG ATG TAT MT GCM GMI ICT GIG CIG GMA AMC268 Ala Ala Ala ie* His Asp Vai Asp His Pro Giy Vai Oar Asn Gin Phe Len Ilie Msn Thr Msn Ser Gin Len Ala Len, Met Tyr Msn Msp Gin Ser Vai Len Gin MsnIII1 III III II II IIII IIIIIIIIIIlIIIl Il I II IIII I
289 Ala Ala Cys Ilie His Asp Vai Asp His Pro Gly Len Thr Msn Gin Phe Len Val Msn Ser Ser Ser Gin Len Ala Len Met Tyr Msn Asp Gin Oar Vai Len Gin Msn
910 CAT CMC CIC OCT GIG GGA TIC AMG CTC CII CMA GMG GM CAT TGC GCM ATC TTT CAG MT CT? ACC AAM AMG GM CGC CAG MA CTC AGG AMA ATG GIG ATT GMC ATG304 His His Len Ala Vai Giy Phe Lye Len Len Gin Gin Gin His Cys Asp Ile Phe Gin Msn Len Thr Lye Lye Gin Mrg Gin Thr Len Mrg Lye Met Vai Ile Asp Met
III II II II III II II IIII II II II II II II II II
325 His His Len Ala Val Aia Ph. Lye Len Len Gin Aen Gin Gly Cys Asp le Phe Cys Msn Met Gin Lye Lye Gin Mrg Gin Thr Len Mrg Lye Met Vai Ile Asp Ile
1018 010 TIA GCA MCT CAT ATG ICC AAM CAC ATG MGC CTC CIG OCT GMC CII AMA MG ATG GTA GMR MC AMA AM GIG MCG MC ICC OGG OTT CIC CTC CTG GAC MAC TAT340 Val Len Ala Thr Msp met Oar Lye His Met Ser Len Len Ala Asp Len Lys Thr Met Vai Gin Thr Lye Lye Vai Thr Oar Ser Gly Vai Len Len Len Asp Msn TyrII1I1I1I1II 1I III II361 Vai Len Oar Thr Msp met Ser Lye His Met Ser Len Len Ala Asp Len Lye Thr Met Val Gin Thr Lye Lye Val Ala Giy Oar Gly Vai Len Len Len Asp Msn Tyr
1126 MIT GA COG AlA CMG OTT CIT COC ARC ATG GTA CAT TOT OCA GCM CIG MGC AMC CCI ACC AMG ICC TTG GMG ITO TAT COG CMA TOG MIT OAT COC AIC ATG GMG GMG376 Thr Msp Mg Ilie Gin Val Len Mrg Msn Met Vai His Cys Ala Asp Len Oar Msn Pro Thr Lye Oar Len Gin Len Tyr Mrg Gin Trp Thr Asp Mrg Ile Met Gin Gin
IIIIIII II III III III III II II IIIIIIIII II III III III III III III III III II397 Thr Asp Mrg Ilie Gin Vai Len Gin Msn Len Val His Cys Ala Asp Len Mer Msn Pro Thr Lye Pro Len Pro Len Tyr Lye Mrg Trp Vai Ala Len Len Met Gin Gin
1234 IT? TIC GMA CA OGA GM AMA GM& COG GMG AG GGA ATG GMG ATT MGC CChAT 1GT CAT AMA CMC MA OCT TCT GIG GMA AMG ICC CMG OTT GGT TIC AlT GCM TMC412 Phs Ph. Gin Gin Gly Asp Lye Gin Mrg Gin Mrg Giy Met Gin Ilie Oar Pro Met Cys Asp Lye His Tbr Ala Ser Val Gin Lye Ser Gin Vai Giy Pha lie Msp TyrIII1 III III tIII IIIII IllIII111III IIIl ~ I IlIlII III III III I II III lIIIII III III III III II433 Phe Ph. Len Gin Gly Asp Lye Gin Mrg Gin Ser Gly Met Msp Ii. Ser Pro Met Cys Asp Mrg His Msn Ala Thr Ile Gin Lye Ser Gin Vai Gly Phe Ile Msp Tyr
1342 All GIC CAT CCA 110 TOG GMG MC TOG GCA CAC CIG 011 CMG CCI OATC?GMTC~ GM All 110 GCM MA CIA GMA CAT AMAC AMG~ TOG TMC CAG MT ATG AT? CCC448 lie Val His Pro Len Trp Gin, Thr Trp Ala Asp Len Val Gin Pro Asp Ala Gin Asp lie Len Asp Thr Len Gin Asp Msn Mg Msn Trp Tyr Gin Ser Met lie Pro
III III III III III III III III III III III III III III III III III III III III III III III III III III III III III III III469 le Val His Pro Len Trp Gln Thr Trp Ala Ser Len Val His Pro Asp Ala Gin Asp Il. Len Asp Thr Len, Gin Gin Asn Mg Asp Tyr Tyr Gin Ser Met le Pro
1450 CMG MC CCC IC? CCA CCA CG GMC GMG AG MC AG GcM TGC GMk GGC CT? ATG GMG AMG TIT CM TIC GMA CTG MCC CTI484 Gin Mrt Pro Ser Pro Pro Len Asp Gin Mrg Ser Mrg Asp Cys, Gin Gly Len Met Gin Lye Pbs Gin Phe Gin Len Thr Len
III III III III III III III III505 Pro Ser Pro Pro Pro Mrt Gly Val Asp Gin Man Pro Gin Gin Asp Mg Ilie Mrg Ph. Gin Val Thr Len Gin Gin Ser Asp Gin Gin Msn Len Ala Gin Len
1531 GMA GM GMG OAT IC? GM& GGA CCG GMA AM GMG GCA GMA GGC CCC AMC TAT TIC AMC MGC MA AMG MA CTI TO? GIG AIC CAT CCA GMG AMACCGAT IC? CTG GMA511 Gin Gin. Gin Asp Mor Gin Gly Pro Gin Lye Gin Gly Gin Gly Pro Msn Tyr Ph. M~r M~r Thr Lye Thr Len Cys Vai IIe Asp Pro Gin Msn Mrg Asp Oar Len GinIII III III III III III III539 Gin Gin Gly Asp Gin M~r Gly Gly Gin Thr Thr Thr Thr Gly Thr Thr Gly Thr Thr Ala, Ala M~r Ala Len Mrg Ala Gly Gly Gly Gly Gly Gly Gly Gly Gly Met
1639 GM MCT GMC ATA GM AT? OCC WA GMA GMC AM IC? dIG AIC GMC MA TMK TCT CCC IC? GIG TOO MCG ICA MCA TIC TAT CC? TGA CCA GCA TOC CMG CTG MGT OG?547OGlnThr Asp IleAsp Ile Ala Tbr GluAsp Lys er LeuIleAspThr Ssr Pro SorValiTrpAg .Thr Ph. Tyr Pro rg Ala Cys ln Lnou er Gly
575 Ala Pro Mrg Thr Gly Gly dye Gin Msn Gin Pro Gin His Gly Gly Met
1747 MGG GCC CAC CIA CCA GMG CCA AGG CC? GCA GMA AM AM GGd CkMdGCGd 11 CMG TTA CIT? GMG TI? OGA Odd MGA ATG, GM GGd COT GMA GCA MAT GC MT? ICC583 Mrg Ala His Len Pro Gin Pro Mgc Pro Ala Gin Asn Lye Gly His Len Ala Len Gin Len Len Gin Pbs, Gly Ala Mrg Met Gin Gly Mrg Gin Ala Msn Mor Mr Ser
1855 010 CTG CCI TGC CT? GCC GGd GMG CI? GGd GMG MC COC MC 10? MCT MGA MC CMG TIC CCA GCA CMG CIA MRT GGC TIG AMA MA GMG GM MGA AM dIG MGA GAT619 Val Len Pro dye Len Ala Gly Gin Len Gly Gin Thr Mrg Mor dyeMer Mrg Mr Gin Pha Pro Ala Gin Len Msn Gly Len Lye Thr Gin Asp Mrg Lye Len Mrg Asp
1963 TGC ICT GCA ATA OGT GT? GMG 000 dIG ICC CCA CMG GIG MCT GMA CTC MT? AMC AM TIC AIC TAT AM Id? CMC CCA ICC TGI 10? dIG CCA MCC 101 GIG Cd? TIT655 dye Mor Ala Ilie Gly Val Gin Gly Len Mer Mrg Gin Val Thr Gin. Leou Thr Msh Men Ph. lie Tyr Lye Ser His Pro Mer dye dye Len Pro Thr dye Val Pro Phe
2071 10TMG?AMTGTITICGTGICTTIGAAATGCCTGTTGMAITCTAGMTTITACCGTT TMMTITGITTCTGGGAAXAAAAAAAAA691 Len
FIG. 2. The nucleotide sequence of the DPD cDNA. The top line shows the nucleotide sequence. Below is the predicted amino acid sequence
of the open reading frame. Termination codons (indicated with a dot) are located at positions 563, 570, 575, and 692. The bottom row showsthe amino acid sequence of the Drosophila dunce gene (28, 38). Identical amino acids in DPD and dunce are indicated with triple vertical lines.
The area of greatest sequence identity is boxed. Numbers on the left indicate nucleotide and amino acid positions.
levels and a heat shock-sensitivity phenotype similar to that To analyze the biochemical properties of the DPD gene
of strains harboring the RAS2vall9 allele (9). lODAB cells were product, crude cell extracts were prepared from 1-liter cul-
transformed with the DPD expression plasmid pADPD, were tures of lODAB that had been transformed with either
assayed for heat shock sensitivity, and were indeed rendered pADNS or pADPD. Phosphodiesterase activity assays were
resistant to heat shock (Fig. 4). performed using cAMP as substrate. Control extracts
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FIG. 3. Analysis of DPD cDNA structure using PCR. Reactions
were carried out as described and the reaction products (either
untreated or cleaved with a restriction endonuclease) were analyzed
on a polyacrylamide gel stained with ethidium bromide. The diagram
at the bottom of the figure illustrates the DPD cDNA and the
positions of primer oligonucleotides (A, B, C, D, E, and F) used. The
locations of the restriction sites for Nsi I and Stu I are also shown,
as is the position of the termination codons (Ter). Each of the four
panels is labeled to indicate the primers used for PCR. Lanes: 1, PCR
product using the cloned DNA as template; 2, PCR product resulting
from the single-stranded cDNA template made from total rat brain
poly(A)+ RNA; 3 and 4, PCR products from the cloned DNA
template or cDNA template, respectively, which have been cleaved
with Nsi I (AC and BC) or Stu I (DE and DF). Restriction fragment
lengths are indicated on the left. These lengths have been calculated
from the known sequence and are in agreement with the observed
mobility of standard DNA fragments run on the same gel.
(lODAB with pADNS) showed no cAMP phosphodiesterase
activity. Results with the controls were unchanged when
performed at 0°C or in the absence of Mg2" and were
comparable to results obtained when no extract was added.
These results indicate that there is indeed no detectable
background phosphodiesterase activity in this strain.
In contrast, considerable cAMP phosphodiesterase activ-
ity was seen in the lODAB strain transformed with pADPD.
The rate of cAMP hydrolysis in cells containing DPD was
measured as a function ofcAMP concentration (Fig. 5). The
deduced Km for cAMP is 3.5 ,M and the calculated Vma,, is
1.1 nmolnmg-l min-1.
The assay conditions were varied to ascertain the cation
preferences of the enzyme and to determine the ability of
calcium and calmodulin to stimulate its activity. In these
assays, Mn2+ can be used as well as Mg2+, and either cation
s510 IU!
control DPD) cont DoI DIPI
PAS2V
cdel pde2-
FIG. 4. Heat shock phenotype. Two heat shock-sensitive yeast
strains, TK161-R2V (RAS2vall9) and 10DAB (pdel-, pde2;), were
transformed with either the pADNS cloning vector alone (control),
or with the pADPD plasmid expressing the rat brain phosphodi-
esterase (DPD). Yeast patches were grown on synthetic medium
plates for 1 day and then replica plated to fresh plates at 30°C (Left)
or to preheated plates and incubated at 55°C for 10 min before
returning to 30°C (Right). Recovery time at 30°C was 36 hr.
Vmax=1 .1 nmole/min/mg
Km=3.5gM
2
C
0.01X
0.00
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FIG. 5. DPD enzyme kinetics. Phosphodiesterase assays were
performed on cell extracts as described with a final Mg2+ concen-
tration of 10 mM. The cAMP concentration was varied from 0.2 to
10 1.M. Two independent determinations were made and background
measured in vector-only extracts was subtracted. Error bars are
based on SD.
in 1 mM final concentration was sufficient. Calcium/calmod-
ulin was unable to stimulate the measured phosphodiesterase
activity in the extract (data not shown). A parallel assay in
which beef heart phosphodiesterase (Boehringer Mannheim)
was used yielded a 6.5-fold stimulation with the addition of
calcium/calmodulin (data not shown). Finally, no cGMP
phosphodiesterase activity was detected in our assays. Beef
heart phosphodiesterase was again used as a positive control.
In addition, cGMP present in amounts 100-fold over substrate
concentrations was unable to inhibit cAMP phosphodi-
esterase activity.
DISCUSSION
Previous workers have cloned a mammalian gene in yeast by
using a biological screen (33). In that case, a homolog to the
cdc2 gene of Schizosaccharomyces pombe was cloned by
screening a cDNA library for complementation of cdc2
mutants. In that library, the cDNAs were inserted proximal
to the simian virus 40 early large tumor antigen promoter. In
our work, we have used a library with mammalian cDNAs
inserted into a yeast expression vector, proximal to a strong
yeast promoter. In addition, we have used Not I linkers for
cDNA cloning, which allows the convenient subcloning of an
entire insert library from one vector to another. We feel that
this will be a generally useful approach for cloning genes from
higher eukaryotes when functional screens are possible in
yeast. This system is particularly useful for the cloning of
other cAMP phosphodiesterases from mammals. The avail-
ability of yeast strains totally lacking endogenous cAMP
phosphodiesterase activity will also facilitate the biochemical
characterization of these new phosphodiesterases.
The mammalian DPD cDNA can encode a protein with a
high degree of amino acid sequence identity (80%) with the
predicted D. melanogaster dunce gene product over an
extended region. The dunce gene has been shown to encode
a high-affinity cAMP phosphodiesterase required for normal
learning and memory in flies (30-32). Compared to the
striking level of sequence identity between DPD and dunce,
the sequence conservation among other known cAMP phos-
phodiesterases is scant (34). Therefore, the DPD-dunce
homology in the conserved region represents more than a
constraint on sequences required for cAMP binding and
hydrolysis and suggests a conservation of interactions with
other components.
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Biochemical characterization of the DPD cDNA product
expressed in yeast indicates that it is a high-affinity cAMP-
specific phosphodiesterase, as is dunce (31, 32). In addition,
DPD activity, as measured in our assays, is not stimulated by
the presence of calcium/calmodulin. This property is shared
with dunce and is distinct from some other phosphodiester-
ases (for a review, see ref. 35). The two proteins, DPD and
dunce, thus appear to have similar biochemical characteris-
tics. However, it should also be noted that DPD encodes a
protein product that shows much less significant homology
(35%) to dunce beyond the previously described highly
conserved region. These nonconserved sequences could re-
sult in an altered or refined function for this mammalian
dunce homolog.
Since the predicted rat DPD product diverges from the
Drosophila dunce gene product, and since we have merely a
single cDNA isolate, we were concerned that the structure of
our cDNA might not reflect the structure of the DPD mRNA.
We have described here the use of PCRs to compare the
structure ofourDPD cDNA with the DPD mRNA. This study
indicates a complete concordance in structure. Our method
should also be applicable to the detection and analysis of
alternate mRNA splicing (see below).
OurDPD sequence encodes a methionine codon at position
46 and the established reading frame remains open through to
position 563, resulting in a protein with a predicted molecular
mass of 60 kDa. The same reading frame, however, is open
beyond the 5' end of the coding strand (Fig. 2). At present,
we cannot say whether the methionine codon at position 46
is the initiating codon for the DPD protein. The coding
sequence is interrupted by three closely spaced terminator
codons. However, the established reading frame then re-
mains open for an additional 116 codons, followed by more
terminator codons, a polyadenylylation consensus signal,
and a poly(A) stretch. This 3' open reading frame could be
incorporated into another dunce-like phosphodiesterase
through alternate splicing. To examine this, we utilized the
PCR method by using oligonucleotides from the conserved
region and from the downstream open reading frame [(oli-
go(D) and -(F), respectively, in Fig. 3]. Our PCR method
reveals no evidence of a DPD mRNA in adult rat brain that
utilizes both the highly conserved domain and the open
reading frame 3' to the stop codons. It should be noted,
however, that a complex transcription pattern involving
alternately spliced messages has been described for the D.
melanogaster dunce locus (36, 37), and this may also be a
feature of the mammalian homolog.
Davis et al. (38) have recently isolated a mammalian dunce
homolog from a rat brain cDNA library by standard nucleic
acid hybridization techniques. The gene they describe is
indeed similar to, though distinct from, the DPD cDNA
described here. Within the highly conserved region, as de-
fined in this work, the predicted amino acid sequences of the
two rat genes are 93% identical. This homology falls off
dramatically, however, in the flanking regions, which show
amino acid identities of 60%o (upstream) and 30% (down-
stream) and require the use of sequence gaps for optimum
alignment. These differences should be sufficient to distin-
guish the two related messages in in situ hybridizations and
to permit the study of their distribution throughout the adult
rat brain and during development.
We thank Ronald L. Davis for sharing his results prior to publi-
cation. We also thank Ilse Wieland and Kenneth Ferguson for
technical advice. We also thank Patricia Bird for her help in prep-
aration of this manuscript. This work was supported by grants from
the National Institutes of Health, the Pfizer Biomedical Research
Award, the American Cancer Society, and the American Business
Foundation for Cancer Research. J.C. is a Schering-Plough Foun-dation Fellow of the Life Sciences Research Foundation, T.M. is
supported by the Damon Runyon-Walter Winchell Cancer Fund, and
M.W. is an American Cancer Society Professor.
1. Powers, S., Kataoka, T., Fasano, O., Goldfarb, M., Strathern,
J., Broach, J. & Wigler, M. (1984) Cell 36, 607-612.
2. Kataoka, T., Powers, S., McGill, C., Fasano, O., Strathern, J.,
Broach, J. & Wigler, M. (1984) Cell 37, 437-445.
3. DeFeo-Jones, D., Scolnick, E. M., Koller, R. & Dhar, R.
(1983) Nature (London) 306, 707-709.
4. Dhar, R., Nieto, A., Koller, R., DeFeo-Jones, D. & Scolnick,
E. (1984) Nucleic Acids Res. 12, 3611-3618.
5. Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T.,
Broek, D., Cameron, S., Broach, J., Matsumoto, K. & Wigler,
M. (1985) Cell 40, 27-36.
6. Sass, P., Field, J., Nikawa, J., Toda, T. & Wigler, M. (1986)
Proc. NatI. Acad. Sci. USA 83, 9303-9307.
7. Kataoka, T., Broek, D. & Wigler, M. (1985) Cell 43, 493-505.
8. Field, J., Nikawa, J., Broek, D., MacDonald, B., Rodgers, L.,
Wilson, I. A., Lerner, R. A. & Wigler, M. (1988) Mol. Cell.
Biol. 8, 2159-2165.
9. Nikawa, J., Sass, P. & Wigler, M. (1987) Mol. Cell. Biol. 7,
3629-3636.
10. Dudai, Y., Jan, Y., Byers, D., Quinn, W. G. & Benzer, S.
(1976) Proc. Natl. Acad. Sci. USA 73, 1684-1688.
11. Tempel, B. L., Bonini, N., Dawson, D. R. & Quinn, W. G.
(1983) Proc. Natl. Acad. Sci. USA 80, 1482-1486.
12. Mandel, M. & Higa, A. (1970) J. Mol. Biol. 53, 159-162.
13. Hanahan, D. (1983) J. Mol. Biol. 166, 557-580.
14. Kataoka, T., Powers, S., Cameron, S., Fasano, O., Goldfarb,
M., Broach, J. & Wigler, M. (1985) Cell 40, 19-26.
15. Nikawa, J.-I., Cameron, S., Toda, T., Ferguson, K. M. &
Wigler, M. (1987) Genes Dev. 1, 931-937.
16. Mortimer, R. K. & Hawthorne, D. C. (1969) in The Yeast, eds.
Rose, A. H. & Harrison, J. S. (Academic, New York), Vol. 1,
pp. 385-460.
17. Ito, H., Fukuda, Y., Murata, K. & Kimura, A. (1983) J.
Bacteriol. 153, 163-168.
18. Holmes, D. S. & Quigley, M. (1981) Anal. Biochem. 114, 193-
197.
19. Katz, L., Kingsbury, D. T. & Helinski, D. E. (1973) J. Bac-
teriol. 114, 477-485.
20. Powers, S., Michaelis, S., Broek, D., Anna, S. S., Field, J.,
Herskowitz, I. & Wigler, M. (1986) Cell 47, 413-422.
21. Sherman, F., Fink, G. R. & Hicks, J. B. (1986) in Laboratory
Course Manualfor Methods in Yeast Genetics, eds. Sherman,
F., Fink, G. R. & Hicks, J. B. (Cold Spring Harbor Lab., Cold
Spring Harbor, NY), pp. 95-97.
22. Bennetzen, J. L. & Hall, B. D. (1982) J. Biol. Chem. 257, 3018-
3025.
23. Ammerer, G. (1983) Methods Enzymol. 101, 192-201.
24. Sanger, F., Nicklen, S. & Coulson, A. R. (1977) Proc. Natl.
Acad. Sci. USA 74, 5463-5467.
25. Biggin, M. D., Gibson, T. J. & Hong, G. F. (1983) Proc. Natl.
Acad. Sci. USA 80, 3963-3965.
26. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter,
W. J. (1979) Biochemistry 18, 5294-5299.
27. Lizardi, P. M. (1983) Methods Enzymol. 96, 24-38.
28. Watson, C. J. & Jackson, J. F. (1984) in DNA Cloning: A
Practical Approach, ed. Glover, D. (IRL, Oxford), pp. 79-88.
29. Saiki, R., Gelfand, D., Stoffe, S., Scharf, S., Higushi, R., Horn,
G., Mullis, K. & Erlich, H. (1988) Science 239, 487-491.
30. Chen, C., Denome, S. & Davis, R. L. (1986) Proc. Natl. Acad.
Sci. USA 83, 9313-9317.
31. Davis, R. L. & Kiger, J. A. (1981) J. Cell Biol. 90, 101-107.
32. Walter, M. F. & Kiger, J. A. (1984) J. Neurosci. 4, 495-501.
33. Lee, M. G. & Nurse, P. (1987) Nature (London) 327, 31-35.
34. Charbonneau, H., Beier, N., Walsh, K. A. & Beavo, J. A.
(1986) Proc. Natl. Acad. Sci. USA 83, 9308-9312.
35. Beavo, J. A. (1988) in Advances in Second Messenger and
Phosphoprotein Research, eds. Greengard, P. & Robinson,
G. A. (Raven, New York), Vol. 22, pp. 1-38.
36. Davis, R. L. & Davidson, N. (1986) Mol. Cell. Biol. 6, 1464-
1470.
37. Chen, C., Malone, T., Beckendorf, S. K. & Davis, R. L. (1987)
Nature (London) 329, 721-724.
38. Davis, R. L., Takayasu, H., Eberwine, M. & Myres, J. (1989)
Proc. Natl. Acad. Sci. USA 86, 3604-3608.
Biochemistry: Colicelli et al.
